Individualized antibiotic dosage regimens for patients with augmented renal clearance

被引:14
作者
Shi, A-Xi [1 ,2 ]
Qu, Qiang [3 ,4 ,5 ]
Zhuang, Hai-Hui [1 ]
Teng, Xin-Qi [1 ]
Xu, Wei-Xin [1 ]
Liu, Yi-Ping [1 ]
Xiao, Yi-Wen [1 ]
Qu, Jian [1 ,5 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Inst Clin Pharm, Dept Pharm, Changsha, Peoples R China
[2] First Hosp Lanzhou Univ, Dept Pharm, Lanzhou, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[5] Changsha Med Univ, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, Changsha, Peoples R China
关键词
augmented renal clearance; antibiotic; pharmacokinetics; pharmacodynamics; individualized; CRITICALLY-ILL PATIENTS; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS INFECTIONS; VITRO ANTIMICROBIAL ACTIVITY; AMOXICILLIN-CLAVULANIC ACID; MONTE-CARLO-SIMULATION; POPULATION PHARMACOKINETICS; ANTIBACTERIAL ACTIVITY; PSEUDOMONAS-AERUGINOSA; CREATININE CLEARANCE;
D O I
10.3389/fphar.2023.1137975
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%-65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs in ARC patients often leads to subtherapeutic concentrations, poor clinical outcomes, and the emergence of multidrug-resistant bacteria. We summarized pharmaceutical, pharmacokinetic, and pharmacodynamic research on the definition, underlying mechanisms, and risk factors of ARC to guide individualized dosing of antibiotics and various strategies for optimizing outcomes.Methods: We searched for articles between 2010 and 2022 in the MEDLINE database about ARC patients and antibiotics and further provided individualized antibiotic dosage regimens for patients with ARC.Results: 25 antibiotic dosage regimens for patients with ARC and various strategies for optimization of outcomes, such as extended infusion time, continuous infusion, increased dosage, and combination regimens, were summarized according to previous research.Conclusion: ARC patients, especially critically ill patients, need to make individualized adjustments to antibiotics, including dose, frequency, and method of administration. Further comprehensive research is required to determine ARC staging, expand the range of recommended antibiotics, and establish individualized dosing guidelines for ARC patients.
引用
收藏
页数:14
相关论文
共 177 条
  • [11] Systemic inflammatory response syndrome (SIRS) Where did it come from and is it still relevant today?
    Balk, Robert A.
    [J]. VIRULENCE, 2014, 5 (01) : 20 - 26
  • [12] Augmented renal clearance: A real phenomenon with an uncertain cause
    Baptista, Joao Pedro
    Roberts, Jason A.
    Udy, Andrew A.
    [J]. ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2019, 38 (04) : 335 - 336
  • [13] Prevalence and Risk Factors for Augmented Renal Clearance in a Population of Critically Ill Patients
    Baptista, Joao Pedro
    Martins, Paulo Jorge
    Marques, Margarida
    Pimentel, Jorge Manuel
    [J]. JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (10) : 1044 - 1052
  • [14] Accuracy of the estimation of glomerular filtration rate within a population of critically ill patients
    Baptista, Joao Pedro
    Neves, Marta
    Rodrigues, Luis
    Teixeira, Luisa
    Pinho, Joao
    Pimentel, Jorge
    [J]. JOURNAL OF NEPHROLOGY, 2014, 27 (04) : 403 - 410
  • [15] Barletta Jeffrey F, 2017, J Trauma Acute Care Surg, V82, P665, DOI 10.1097/TA.0000000000001387
  • [16] CEFEPIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE
    BARRADELL, LB
    BRYSON, HM
    [J]. DRUGS, 1994, 47 (03) : 471 - 505
  • [17] Impact of augmented renal clearance on the pharmacokinetics of linezolid: Advantages of continuous infusion from a pharmacokinetic/pharmacodynamic perspective
    Barrasa, Helena
    Soraluce, Amaia
    Uson, Elena
    Sainz, Javier
    Martin, Alejandro
    Angel Sanchez-Izquierdo, Jose
    Maynar, Javier
    Rodriguez-Gascon, Alicia
    Isla, Arantxazu
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 93 : 329 - 338
  • [18] Pharmacokinetics of linezolid in critically ill patients on continuous renal replacement therapy: Influence of residual renal function on PK/PD target attainment
    Barrasa, Helena
    Soraluce, Amaia
    Isla, Arantxazu
    Martin, Alejandro
    Maynar, Javier
    Canut, Andres
    Angel Sanchez-Izquierdo, Jose
    Rodriguez-Gascon, Alicia
    [J]. JOURNAL OF CRITICAL CARE, 2019, 50 : 69 - 76
  • [19] Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically III Children with Normal and Augmented Renal Clearance
    Beranger, Agathe
    Benaboud, Sihem
    Urien, Saik
    Moulin, Florence
    Bille, Emmanuelle
    Lesage, Fabrice
    Zheng, Yi
    Genuini, Mathieu
    Gana, Ines
    Renolleau, Sylvain
    Hirt, Deborah
    Treluyer, Jean-Marc
    Oualha, Mehdi
    [J]. CLINICAL PHARMACOKINETICS, 2019, 58 (02) : 223 - 233
  • [20] Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling
    Bergen, Phillip J.
    Bulitta, Jurgen B.
    Kirkpatrick, Carl M. J.
    Rogers, Kate E.
    McGregor, Megan J.
    Wallis, Steven C.
    Paterson, David L.
    Lipman, Jeffrey
    Roberts, Jason A.
    Landersdorfer, Cornelia B.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (09) : 2509 - 2520